Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Plos One|November 25, 2015
Computed Tomography (CT) Scanning Facilitates Early Identification of Neonatal Cystic Fibrosis PigletsAntoine Guillon, Claire Chevaleyre, Celine Barc, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2013
Population pharmacokinetics of oseltamivir: pediatrics through geriatricsMohamed A Kamal, Scott A Van Wart, Craig R Rayner, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2019
Apotransferrin in Combination with Ciprofloxacin Slows Bacterial Replication, Prevents Resistance Amplification, and Increases Antimicrobial Regimen EffectPaul G Ambrose, Brian D VanScoy, Brian M Luna, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation SolutionSujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumoniaSujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Open Forum Infectious Diseases|September 4, 2024
Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute PyelonephritisSujata M Bhavnani, Jeffrey P Hammel, Christopher M Rubino, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2019
Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST)Jason M Pogue, Ronald N Jones, John S Bradley, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with CeftolozaneBrian Vanscoy, Rodrigo E Mendes, Jennifer McCauley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2018
Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant TuberculosisDevyani Deshpande, Jotam G Pasipanodya, Shashikant Srivastava, et al.
Antimicrobial Agents and Chemotherapy|February 11, 2010
Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis modelStanley C Gill, Christopher M Rubino, Jennifer Bassett, et al.
Pageof 17